The Philadelphia (Ph)-chromosome, or translocation t (9,22), was identified as the cytogenetic hallmark of CML, and the BCR::ABL1 fusion gene was later recognized as the central pathophysiological driver of the disease. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.